Chromatin contributions to the regulation of innate immunity

Annual Review of Immunology

Volumn 32, Issue , 2014, Pages 489-511

  Smale, Stephen T ^a   Tarakhovsky, Alexander ^b   Natoli, Gioacchino ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Chromatin; Epigenetics; Innate immunity; Macrophages; Transcription

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR;

ADAPTIVE IMMUNITY; CELL SPECIFICITY; CELL TYPE; CHROMATIN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; MEMORY CELL; MICROBIAL IMMUNITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CHROMATIN; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFLAMMATION; ORGAN SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 84896919030     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-031210-101303     Document Type: Review

References (146)

1. Medzhitov R, Janeway CA Jr. 1997. Innate immunity: impact on the adaptive immune system. Curr. Opin. Immunol. 9:4-9
2. Medzhitov R, Janeway CA Jr. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-98
3. Schenten D, Medzhitov R. 2011. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 109:87-124
4. Janeway CA Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54(Pt. 1):1-13
5. Lamaitre B, Nicolas E, Michaut L, Reichhart JM,Hoffmann JA. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-83
6. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-97
7. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805-20
8. Kumar H, Kawai T, Akira S. 2011. Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30:16-34
9. Medzhitov R, Horng T. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9:692-703
10. Smale ST. 2010. Selective transcription in response to an inflammatory stimulus. Cell 140:833-44
11. Natoli G. 2010. Maintaining cell identity through global control of genomic organization. Immunity 33:12-24
12. Natoli G, Ghisletti S, Barozzi I. 2011. The genomic landscapes of inflammation. Genes Dev. 25:101-6
13. Smale ST. 2012. Transcriptional regulation in the innate immune system. Curr. Opin. Immunol. 24:51-57
14. Biswas SK, Lopez-Collazo E. 2009. Endotoxin tolerance: new mechanisms, molecules, and clinical significance. Trends Immunol. 30:475-87
15. Monticelli S, Natoli G. 2013. Short-termmemory of danger signals and environmental stimuli in immune cells. Nat. Immunol. 14:777-84
16. Lyakh L, Trinchieri G, Provezza L, Carra G, Gerosa F. 2008. Regulation of interleukin-12/interleukin- 23 production and the T-helper 17 response in humans. Immunol. Rev. 226:112-31
17. Gilmore TD, Gerondakis S. 2011. The c-Rel transcription factor in development and disease. Genes Cancer 2:695-711
18. Smale ST. 2012. Dimer-specific regulatorymechanisms within theNF-κBfamily of transcription factors. Immunol. Rev. 246:193-204
19. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, et al. 2007. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39:311-18
20. Jeong KW, Kim K, Situ AJ, Ullmer TS, An W, Stallcup MR. 2011. Recognition of enhancer elementspecific histone methylation by TIP60 in transcriptional activation. Nat. Struct. Mol. Biol. 18:1358-65
21. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, et al. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA 107:21931-36
22. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470:279-83
23. Otsuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, et al. 2013. Latent enhancers activated by stimulation in differentiated cells. Cell 152:157-71
24. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, et al. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459:108-12
25. Chen J, Li Q. 2011. Life and death of transcriptional co-Activator p300. Epigenetics 6:957-61
26. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, et al. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457:854-58
27. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, et al. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32:317-28
28. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-77
29. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, et al. 2010. Simple combinations of lineagedetermining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38:576-89
30. DeKoter RP, Singh H. 2000. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288:1439-41
31. Gualdi R, Bossard P, Zheng M, Hamada Y, Coleman JR, Zaret KS. 1996. Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev. 10:1670-82
32. Smale ST. 2010. Pioneer factors in embryonic stem cells and differentiation. Curr. Opin. Genet. Dev. 20:519-26
33. Zaret KS, Carroll JS. 2011. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25:2227-41
34. Xu J, Pope SD, Jazirehi AR, Attema JL, Papathanasiou P, et al. 2007. Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissue-specific enhancers in embryonic stem cells. Proc. Natl. Acad. Sci. USA 104:12377-82
35. Xu J, Watts JA, Pope SD, Gadue P, Kamps M, et al. 2009. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic stem and induced pluripotent stem cells. Genes Dev. 23:2824-38
36. de Wit E, de Laat W. 2012. A decade of 3C technologies: insights into nuclear organization. Genes Dev. 26:11-24
37. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, et al. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465:182-87
38. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, et al. 2010. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 8:e1000384
39. Koch F, Fenouil R, Gut M, Cauchy P, Albert TK, et al. 2011. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat. Struct. Mol. Biol. 18:956-63
40. Natoli G, Andrau JC. 2012. Noncoding transcription at enhancers: general principles and functional models. Annu. Rev. Genet. 46:1-19
41. Lam MT, Cho H, Lesch HP, Gosselin D, Heinz S, et al. 2013. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 498:511-15
42. Yamamoto KR, Alberts BM. 1976. Steroid receptors: elements for modulation of eukaryotic transcription. Annu. Rev. Biochem. 45:721-46
43. Herschman HR. 1991. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60:281-319
44. Fowler T, Ren R, Roy AL. 2011. Regulation of primary response genes. Mol. Cell 44:348-60
45. Sen R, Baltimore D. 1986. Inducibility of kappa immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism. Cell 47:921-28
46. Hayden MS, Ghosh S. 2012. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26:203-34
47. Price MA, Hill C, Treisman R. 1996. Integration of growth factor signals at the c-fos serum response element. Philos. Trans. R. Soc. B 351:551-59
48. Posem G, Treisman R. 2006. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 16:588-96
49. Almer A, Horz W. 1986. Nuclease hypersensitive regions with adjacent positioned nucleosomes mark the gene boundaries of the PHO5/PHO3 locus in yeast. EMBO J. 5:2681-87
50. Almer A, Rudolph H, Hinnen A, Horz W. 1986. Removal of positioned nucleosomes from the yeast PHO5 promoter upon PHO5 induction releases additional upstream activation DNA elements. EMBO J. 5:2689-96
51. McAndrew PC, Svaren J, Martin SR, Horz W, Goding CR. 1998. Requirements for chromatin modulation and transcription activation by the Pho4 acidic activation domain. Mol. Cell. Biol. 18:5818-27
52. Verdin E, Paras P, Van Lint C. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12:3249-59
53. Richard-Foy H, Hager GL. 1987. Sequence-specific positioning of nucleosomes over the steroidinducible MMTV promoter. EMBO J. 6:2321-28
54. Fragaso G, John S, Roberts MS, Hager GL. 1995. Nucleosome positioning on the MMTV LTR result from the frequency-biased occupancy of multiple frames. Genes Dev. 9:1933-47
55. Siebenlist U, Durand DB, Bressler P, Holbrook NJ, Norris CA, et al. 1986. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells. Mol. Cell. Biol. 6:3042-49
56. Ward SB, Hernandez-Hoyas G, Chen F, Waterman M, Reeves R, Rothenberg EV. 1998. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions. Nucleic Acids Res. 26:2923-34
57. Agarwal S, Rao A. 1998. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765-75
58. Weinmann AS, Plevy SE, Smale ST. 1999. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. Immunity 11:665-75
59. Agalioti T, Lomvardas S, Parekh B, Yie J,Maniatis T, Thanos D. 2000. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 103:667-78
60. Parekh BS, Maniatis T. 1999. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-βpromoter. Mol. Cell 3:125-29
61. Peterson CL, Workman JL. 2000. Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr. Opin. Genet. Dev. 10:187-92
62. Li B, Carey M,Workman JL. 2007. The role of chromatin during transcription. Cell 128:707-19
63. Carey M, Peterson CL, Smale ST. 2009. Transcriptional Regulation in Eukaryotes: Concepts, Strategies, and Techniques. New York: Cold Spring Harbor Lab. 2nd ed.
64. Natoli G. 2009. Control ofNF-κB-dependent transcriptional responses by chromatin organization. Cold Spring Harb. Perspect. Biol. 1:a000224
65. Sen R, Smale ST. 2010. Selectivity of the NF-κB response. Cold Spring Harb. Perspect. Biol. 2:a000257
66. Smale ST. 2011. Hierarchies of NF-κB target-gene regulation. Nat. Immunol. 12:689-94
67. Saccani S, Pantano S, Natoli G. 2001. Two waves of nuclear factor κB recruitment to target promoters. J. Exp. Med. 193:1351-59
68. Ramirez-Carrozzi VR,Nazarian AA, Li CC, Gore SL, Sridharan R, et al. 2006. Selective and antagonistic functions of SWI/SNF andMi-2βnucleosome remodeling complexes during an inflammatory response. Genes Dev. 20:282-96
69. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, et al. 2009. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138:114-28
70. Wang W, Cote J, Xue J, Zhou S, Khavari PA, et al. 1996. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15:5370-82
71. Hargreaves DC,Horng T, MedzhitovR. 2009. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138:129-45
72. Drew HR, Travers AA. 1985. DNA bending and its relation to nucleosome positioning. J. Mol. Biol. 196:261-82
73. Satchwell SC, Drew HR, Travers AA. 1986. Sequence periodicities in chicken nucleosome core DNA. J. Mol. Biol. 191:659-75
74. Lowary PT, Widom J. 1998. New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning. J. Mol. Biol. 276:19-42
75. Fenouil R, Cauchy P, Koch F, Descostes N, Cabeza JZ, et al. 2012. CpG islands and GC content dictate nucleosome depletion in a transcription- independent manner at mammalian promoters. Genome Res. 22:2399-408
76. Lone IN, ShuklaMS, Charles Richard JL, Peshev ZY, Dimitrov S, Angelov D. 2013. Binding of NF-κB to nucleosomes: effect of translational positioning, nucleosome remodeling, and linker histone H1. PLoS Genet. 9:e1003830
77. Weinmann AS,MitchellDM, Sanjabi S, BradleyMN, Hoffmann A, et al. 2001. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat. Immunol. 2:51-57
78. Kishimoto T. 2010. IL-6: from its discovery to clinical applications. Int. Immunol. 22:347-52
79. Kimura A, Kishimoto T. 2010. IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 40:1830-35
80. Bhatt DM, Pandya-Jones A, Tong AJ, Barozzi I, Lissner MM, et al. 2012. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 150:279-90
81. De Santa F, Narang V, Yap ZH, Tusi BK, Burgold T, et al. 2009. Jmjd3 contributes to the control of gene expression in LPS-Activated macrophages. EMBO J. 28:3341-52
82. Simon JA, Kingston RE. 2013. Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol. Cell 49:808-24
83. Perkins ND. 2006. Post-translational modifications regulating the activity and function of the nuclear factor κB pathway. Oncogene 25:6717-30
84. Zhong H, Voll RE, Ghosh S. 1998. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the co-Activator CBP/p300. Mol. Cell 1:661-71
85. Chen LF, Fischle W, Verdin E, Greene WC. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293:1653-57
86. Zhong H, May MJ, Jimi E, Ghosh S. 2002. Phosphorylation of nuclear NF-κB governs its association with either HDAC-1 or CBP/p300: a mechanism for regulating the transcriptional activity of NF-κB. Mol. Cell 9:625-36
87. Duran A, Diaz-Meco MT, Moscat J. 2003. Essential role of RelA Ser311 phosphorylation by ?PKC in NF-κB transcriptional activation. EMBO J. 22:3910-18
88. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, et al. 2004. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23:2369-80
89. Dong J, Jimi E, ZhongH,HaydenMS, Ghosh S. 2008. Epigenetic regulation ofNF-κB dependent gene expression. Genes Dev. 22:1159-73
90. Ea CK, Baltimore D. 2009. Regulation of NF-κB activity through lysine monomethylation of p65. Proc. Natl. Acad. Sci. USA 106:18972-77
91. Yang XD, Yuang B, Li M, Lamb A, Kelleher NL, Chen LF. 2009. Negative regulation of NF-κB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J. 28:1055-66
92. Huang B, Yang XD, Zhou MM, Ozato K, Chen LF. 2009. Brd4 coactivates transcriptional activation of NF-κB via specific binding to acetylated RelA. Mol. Cell. Biol. 29:1375-87
93. Yang XD, Tajkhorshid E, Chen LF. 2010. Functional interplay between acetylation and methylation of the RelA subunit of NF-κB. Mol. Cell. Biol. 30:2170-80
94. Levy D, Kuo AJ, Chang Y, Schaefer U, Kitson C, et al. 2011. Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling. Nat. Immunol. 12:29-36
95. Allison DF, Wamsley JJ, Kumar M, Li D, Gray LG, et al. 2012. Modification of RelA by O-linked N-Acetylglucosamine links glucose metabolism toNF-κB acetylation and transcription. Proc. Natl. Acad. Sci. USA 109:16888-93
96. Liu Y,MayoMW, Nagji AS, Smith PW, RamseyCS, et al. 2012. Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1. Oncogene 31:1143-54
97. Lu T, Yang M, Huang DB, Wei H, Ozer GH, et al. 2013. Role of lysine methylation of NF-κB in differential gene regulation. Proc. Natl. Acad. Sci. USA 110:13510-15
98. WeiH,Wang B,MiyagiM, She Y, Gopalan B, et al. 2013. PRMT5 dimethylates P30 of the p65 subunit to activate NF-κB. Proc. Natl. Acad. Sci. USA 110:13516-21
99. Ramakrishnan P, Clark PM, MasonDE, Peters EC,Hsieh-Wilson LC, BaltimoreD. 2013. Activation of the transcriptional function of the NF-κB protein c-Rel by O-GlcNAc glycosylation. Sci. Signal. 6:ra75
100. Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, et al. 2005. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-κB- dependent gene expression. EMBO J. 24:85-96
101. Hassa PO, Covic M, BedfordMT, HottigerMO. 2008. Protein arginine methyltransferase 1 coactivates NF-κB-dependent gene expression synergistically with CARM1 and PARP1. J. Mol. Biol. 377:668-78
102. Wan F, Anderson DE, Barnitz RA, Snow A, Bidere N, et al. 2007. Ribosomal protein S3: a KH domain subunit in NF-κB complexes that mediates selective gene regulation. Cell 131:927-39
103. Yamamoto M, Takeda K. 2008. Role of nuclear IκB proteins in the regulation of host immune responses. J. Infect. Chemother. 14:265-69
104. van Essen D, Engist B, Natoli G, Saccani S. 2009. Two modes of transcriptional activation at native promoters by NF-κB p65. PLoS Biol. 7:e73
105. Ea CK, Hao S,Yeo KS, BaltimoreD. 2012.EHMT1protein binds to nuclear factor-κB p50 and represses gene expression. J. Biol. Chem. 287:31207-17
106. Mukherjee SP, Behar M, Birnbaum HA, Hoffmann A, Wright PE, Ghosh G. 2013. Analysis of the RelA:CBP/p300 interaction reveals its involvement in NF-κB-driven transcription. PLoS Biol. 11:e1001647
107. Zou YR, SunshineMJ, Taniuchi I, Hatam F, Killeen N, Littman DR. 2001. Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage. Nat. Genet. 29:332-36
108. Gialitakis M, Sellars M, Littman DR. 2012. The epigenetic landscape of lineage choice: lessons from the heritability of CD4 and CD8 expression. Curr. Top. Microbiol. Immunol. 356:165-88
109. Ptashne M. 2013. Epigenetics: core misconcept. Proc. Natl. Acad. Sci. USA 110:7101-13
110. Ivashkiv LB. 2011. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur. J. Immunol. 41:2477-81
111. Ivashkiv LB. 2013. Epigenetic regulation of macrophage polarization and function. Trends Immunol. 34:216-23
112. Foster SL,Hargreaves DC,Medzhitov R. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447:972-78
113. Yan Q, Carmody RJ, Qu Z, Ruan Q, Jager J, et al. 2012. Nuclear factor-κB binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome. Proc. Natl. Acad. Sci. USA 109:14140-45
114. Gasparini C, Feldmann M. 2012. NF-κB as a target for modulating inflammatory responses. Curr. Pharm. Des. 18:5735-45
115. Zeng L, Zhou MM. 2002. Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 513:124-28
116. Mujtaba S, Zeng L, Zhou MM. 2007. Structure and acetyl-lysine recognition of the bromodomain. Oncogene 26:5521-27
117. Zippo A, Serafini R, Rocchigiani M, Pennacchini S, Krepelova A, Oliviero S. 2009. Histone crosstalk between H3S10ph and K4K16ac generates a histone code that mediates transcription elongation. Cell 138:1122-36
118. Filippakopoulos P, Knapp S. 2012. The bromodomain interaction module. FEBS Lett. 586:2692-704
119. Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert JP, et al. 2012. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149:214-31
120. Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K. 2003. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. USA 100:8758-63
121. McBride AA, McPhillips MG, Oliveira JG. 2004. Brd4: tethering, segregation and beyond. Trends Microbiol. 12:527-29
122. Rahman S, Sowa ME, Ottinger M, Smith JA, Shi Y, et al. 2011. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol. Cell. Biol. 31:2641-52
123. Schr oder S,Cho S, Zeng L, ZhangQ,KaehlckeK, et al. 2012. Two-pronged binding with bromodomaincontaining protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes. J. Biol. Chem. 287:1090-99
124. Peterlin BM, Price DH. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23:297-305
125. Zhou Q, Li T, Price DH. 2012. RNA polymerase II elongation control. Annu. Rev. Biochem. 81:119-43
126. Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, et al. 2011. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478:529-33
127. Belkina AC, Denis GV. 2012. BET domain co-regulators in obesity, inflammation and cancer. Nat. Rev. Cancer 12:465-77
128. Salter-Cid L, FlajnikMF. 1995. Evolution and developmental regulation of the major histocompatibility complex. Crit. Rev. Immunol. 15:31-75
129. Belkina AC, Nikolajczyk BS, Denis GV. 2013. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J. Immunol. 190:3670-78
130. Taverna SD, LiH, Ruthenburg AJ, Allis CD, Patel DJ. 2007. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 14:1025-40
131. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, et al. 2010. Selective inhibition of BET bromodomains. Nature 468:1067-73
132. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, et al. 2010. Suppression of inflammation by a synthetic histone mimic. Nature 468:1119-23
133. Bierne H, Cossart P. 2012. When bacteria target the nucleus: the emerging family of nucleomodulins. Cell. Microbiol. 14:622-33
134. Bierne H, Hamon M, Cossart P. 2012. Epigenetics and bacterial infections. Cold Spring Harb. Perspect. Med. 2:a010272
135. Fonseca GJ, Thillainadesan G, Yousef AF, Ablack JN, Mossman KL, et al. 2012. Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe 11:597-606
136. Mueller CL, Jaehning JA. 2002. Ctr9, Rtf1, and Leo1 are components of the PAF1/RNA polymerase II complex. Mol. Cell. Biol. 22:1971-80
137. Jaehning JA. 2010. The Paf1 complex: platform or player in RNA polymerase II transcription? Biochim. Biophys. Acta 1799:379-88
138. Kim J, Roeder RG. 2009. Direct Bre1-Paf1 complex interactions and RING finger-independent Bre1- Rad6 interactions mediate histone H2B ubiquitylation in yeast. J. Biol. Chem. 284:20582-92
139. Kim J, Guermah M, McGinty RK, Lee JS, Tang Z, et al. 2009. RAD6-mediated transcription-coupled H2B ubiquitylation directly stimulates H3K4 methylation in human cells. Cell 137:459-71
140. Lee JS, Shukla A, Schneider J, Swanson SK, WashburnMP, et al. 2007. Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS. Cell 131:1084-96
141. Xiao T, Kao CF, Krogan NJ, Sun ZW, Greenblatt JF. 2005. Histone H2B ubiquitylation is associated with elongating RNA polymerase II. Mol. Cell. Biol. 25:637-51
142. Luo Z, LinC, Shilatifard A. 2012. The super elongation complex (SEC) family in transcriptional control. Nat. Rev. Mol. Cell Biol. 13:543-47
143. Haye K, Burmakina S, Moran T, Garcia-Sastre A, Fernandez-Sesma A. 2009. The NS1 protein of a human influenza virus inhibits type 1 interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J. Virol. 83:6849-62
144. Hale BG, Randall RE, Ortin J, Jackson D. 2008. Themultifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89:2359-76
145. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. 2007. Multiple anti-interferon actions of the influenza A virus NS1 protein. J. Virol. 81:7011-21
146. Marazzi I, Ho JS, Kim J, Manicassamy B, Dewell S, et al. 2012. Suppression of the antiviral response by an influenza histone mimic. Nature 483:428-33